These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 27264648
1. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia. Ahmad N, Ahmad R, Naqvi AA, Alam MA, Ashafaq M, Samim M, Iqbal Z, Ahmad FJ. Int J Biol Macromol; 2016 Oct; 91():640-55. PubMed ID: 27264648 [Abstract] [Full Text] [Related]
2. PNIPAM nanoparticles for targeted and enhanced nose-to-brain delivery of curcuminoids: UPLC/ESI-Q-ToF-MS/MS-based pharmacokinetics and pharmacodynamic evaluation in cerebral ischemia model. Ahmad N, Ahmad I, Umar S, Iqbal Z, Samim M, Ahmad FJ. Drug Deliv; 2016 Sep; 23(7):2095-2114. PubMed ID: 25237726 [Abstract] [Full Text] [Related]
3. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia. Ahmad N, Ahmad R, Alam MA, Ahmad FJ. Drug Res (Stuttg); 2018 Oct; 68(10):584-595. PubMed ID: 29669380 [Abstract] [Full Text] [Related]
4. Brain-targeted glycyrrhizic-acid-loaded surface decorated nanoparticles for treatment of cerebral ischaemia and its toxicity assessment. Ahmad N, Al-Subaiec AM, Ahmad R, Sharma S, Alam MA, Ashafaq M, Abdur Rub R, Ahmad FJ. Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):475-490. PubMed ID: 30739499 [Abstract] [Full Text] [Related]
5. Intranasal delivery of quercetin-loaded mucoadhesive nanoemulsion for treatment of cerebral ischaemia. Ahmad N, Ahmad R, Naqvi AA, Alam MA, Ashafaq M, Abdur Rub R, Ahmad FJ. Artif Cells Nanomed Biotechnol; 2018 Jun; 46(4):717-729. PubMed ID: 28604104 [Abstract] [Full Text] [Related]
6. Quantification and evaluation of thymoquinone loaded mucoadhesive nanoemulsion for treatment of cerebral ischemia. Ahmad N, Ahmad R, Alam MA, Samim M, Iqbal Z, Ahmad FJ. Int J Biol Macromol; 2016 Jul; 88():320-32. PubMed ID: 26976069 [Abstract] [Full Text] [Related]
7. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery. Rukmangathen R, Yallamalli IM, Yalavarthi PR. Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571 [Abstract] [Full Text] [Related]
8. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain. Hanafy AS, Farid RM, ElGamal SS. Drug Dev Ind Pharm; 2015 Aug; 41(12):2055-68. PubMed ID: 26133084 [Abstract] [Full Text] [Related]
9. Preparation of Chitosan Okra Nanoparticles: Optimization and Evaluation as Mucoadhesive Drug Delivery System. Brar V, Kaur G. Pharm Nanotechnol; 2018 Aug; 6(3):180-191. PubMed ID: 30101724 [Abstract] [Full Text] [Related]
10. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Fazil M, Md S, Haque S, Kumar M, Baboota S, Sahni JK, Ali J. Eur J Pharm Sci; 2012 Aug 30; 47(1):6-15. PubMed ID: 22561106 [Abstract] [Full Text] [Related]
15. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis. Saini D, Fazil M, Ali MM, Baboota S, Ali J. Drug Deliv; 2015 Aug 30; 22(6):823-36. PubMed ID: 24725026 [Abstract] [Full Text] [Related]
18. Quantification of rutin in rat's brain by UHPLC/ESI-Q-TOF-MS/MS after intranasal administration of rutin loaded chitosan nanoparticles. Ahmad N, Ahmad R, Naqvi AA, Alam MA, Samim M, Iqbal Z, Ahmad FJ. EXCLI J; 2016 Aug 30; 15():518-531. PubMed ID: 28096783 [Abstract] [Full Text] [Related]